Cytodyn Inc (CYDY)

[LaundryMoney]

You make valid points on tempering expectations. I think if they can license the prostrate cancer test, and the tender offer succeeds in getting the needed capital for the rest of the year(28 million), they could keep the combo HIV indication in house and not license. Like u said we'd only get a small percentage that way. We already would owe the previous cydy owners a license % of what we sell. I believe it was mentioned at the shareholder meeting that some major financial was urging them not to work with Gilead (assuming licensing here...don't actually know for sure...nor was the financial mentioned). Looking back at gileads chart(max timeline on Google finance) it took several years to make double digits. I could see the same wait here as current trials have been moving along slower than anticipated. Then again each biotech is it's own story and I've given up trying to figure out the sanity of some investors. (Multi billion dollar canibus valuations with barely any revenue?) Who knows. I do think HIV efficacy endpoints derisks the company a bit for the FDA approval. If they don't accept the application, then I'm calling out big pharma corruption, because lesser drugs with more side effects have already been approved. Something's fishy if leronlimab gets denied.